ALUNBRIG (BRIGATINIB) TABLETS

Alunbrig (brigatinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.

ALUNBRIG is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC).

What is Alunbrig (Brigatinib Tablets)?

Alunbrig (brigatinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Alunbrig is used to treat non-small cell lung cancer that has spread to other parts of the body (metastatic), when treatment with other cancer medicine has not been successful.

Alunbrig is used only if your cancer has a specific genetic marker (an abnormal “ALK” gene). Your doctor will test you for this gene.

How to buy Alunbrig (Brigatinib Tablets) in India?

Alunbrig (Brigatinib Tablets) suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

The order for Alunbrig (Brigatinib Tablets) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

What are the indications and usage ?

ALUNBRIG is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a
confirmatory trial.

Uses of Alunbrig (Brigatinib Tablets):

Alunbrig is used to treat non-small cell lung cancer that has spread to other parts of the body (metastatic), when treatment with other cancer medicine has not been successful.

What are the facts of Alunbrig (Brigatinib Tablets) ?

Medicine Name: Alunbrig
Generic Name: Brigatinib
Approval Date: April 28, 2017
Company Name: ARIAD Pharmaceuticals, Inc.

Dosage forms and strengths of Alunbrig (Brigatinib Tablets).

90 mg orally once daily for the first 7 days;

if 90 mg is tolerated during the first 7 days, increase the dose to 180 mg orally once daily.

Alunbrig (Brigatinib) is available.

Get In Touch

Alunbrig (Brigatinib Tablets) suppliers in India

ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Alunbrig (Brigatinib Tablets) on prescription and Import License in Patient’s Name only.

For foreign countries patients, Alunbrig (Brigatinib Tablets) can be made available in Send your inquiry to find Alunbrig (Brigatinib Tablets) in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Alunbrig (Brigatinib Tablets)

For Alunbrig (Brigatinib Tablets) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details